Which medications should a patient with a 90% right coronary artery stenosis be prescribed?

Medications for 90% RCA Occlusion

Your patient with 90% right coronary artery stenosis requires lifelong aspirin 75-100 mg daily, a high-intensity statin, and antianginal therapy starting with a beta-blocker, with consideration for revascularization given the critical stenosis. 1

Core Medical Therapy

Antiplatelet Therapy

• Aspirin 75-100 mg daily is mandatory for patients with significant obstructive coronary artery disease, even without prior MI or revascularization 1
• If aspirin is not tolerated, clopidogrel 75 mg daily is an equally effective alternative 1
• After PCI (if performed), dual antiplatelet therapy (DAPT) will be required for a defined period, followed by lifelong single antiplatelet therapy

Lipid Management

• High-intensity statin therapy is essential for all patients with obstructive CAD 2, 3
• Target LDL-C <100 mg/dL, with consideration of <70 mg/dL given the severity of stenosis 3
• Statins have proven mortality benefit in secondary prevention

Blood Pressure Control

• Beta-blockers are first-line for both blood pressure control and antianginal effect 1, 3
• ACE inhibitors should be added for cardiovascular protection 4, 3
• If beta-blockers or ACE inhibitors are not tolerated, calcium channel blockers or ARBs are acceptable alternatives 3

Antianginal Strategy

First-Line Therapy

• Short-acting nitrates (sublingual nitroglycerin) for immediate symptom relief 1
• Beta-blockers as initial antianginal therapy for most patients with chronic coronary syndrome 1
  • Examples: carvedilol 6.25 mg BID uptitrated, or metoprolol, atenolol

Second-Line/Add-On Therapy (if symptoms persist)

If beta-blocker monotherapy is insufficient:

1. Combination of beta-blocker with dihydropyridine calcium channel blocker (e.g., amlodipine) is the preferred escalation 1

2. Long-acting nitrates or ranolazine should be considered as add-on therapy 1

3. Nicorandil or trimetazidine may be considered as additional options, though availability varies by region 1

Critical Clinical Considerations

Revascularization Decision

With 90% RCA stenosis, this patient likely has:

• Fractional flow reserve (FFR) ≤0.80 indicating hemodynamically significant stenosis
• High likelihood of benefiting from PCI or CABG, particularly if symptomatic or if the RCA supplies significant myocardium 4

The decision between optimal medical therapy alone versus revascularization should be made urgently, as this represents critical stenosis with high risk for complete occlusion and inferior MI.

Post-Revascularization Adjustments

If PCI is performed:

• DAPT (aspirin + P2Y12 inhibitor) for minimum 6-12 months depending on stent type and bleeding risk 1
• Continue all other medical therapy lifelong
• Beta-blockers remain beneficial even after successful revascularization

Common Pitfalls to Avoid

• Do not delay revascularization evaluation in a patient with 90% stenosis—this is critical disease
• Do not use ivabradine as add-on therapy if LVEF >40% and no heart failure 1
• Do not combine ivabradine with non-dihydropyridine calcium channel blockers (verapamil, diltiazem) 1
• Do not use nitrates with phosphodiesterase inhibitors (sildenafil, tadalafil) 1
• Do not stop antiplatelet therapy without cardiology consultation, even if minor bleeding occurs

Risk Factor Modification

Beyond medications:

• Smoking cessation is mandatory 2
• Exercise and weight loss programs
• Diabetes control if present
• These lifestyle modifications are as important as pharmacotherapy for preventing disease progression